Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
J Appl Microbiol ; 131(1): 460-469, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33289232

ABSTRACT

AIMS: The objective of this study was to evaluate the effect of treatment with the probiotic Saccharomyces boulardii with or without metronidazole in experimental giardiasis. METHODS AND RESULTS: The effect of treatment with S. boulardii with or without metronidazole on the intestinal mucosa, the antioxidant defence system and the parasitic load was determined in experimental giardiasis. Eight groups of animals with infection and/or treatment with the probiotic and/or drugs for 1 week after infection with Giardia lamblia were used. A reduction of approximately 90% in the parasitic load was observed in all the treated groups. Saccharomyces boulardii attenuated the damage caused by infection in the intestinal mucosa preserving its architecture and inhibiting the oxidative stress induced by parasite and metronidazole. CONCLUSIONS: Saccharomyces boulardii was effective alone or in combination with metronidazole in resolving already established G. lamblia infection. SIGNIFICANCE AND IMPACT OF THE STUDY: These results suggest the use of S. boulardii as an alternative treatment for giardiasis mainly in cases of resistance or intolerance to conventional treatment.


Subject(s)
Antiprotozoal Agents/therapeutic use , Giardiasis/drug therapy , Probiotics/therapeutic use , Saccharomyces boulardii/physiology , Animals , Disease Models, Animal , Gerbillinae , Giardia lamblia/drug effects , Giardiasis/parasitology , Intestinal Mucosa/drug effects , Intestinal Mucosa/parasitology , Metronidazole/therapeutic use , Oxidative Stress/drug effects , Parasite Load , Probiotics/pharmacology
2.
J Appl Microbiol ; 129(6): 1706-1719, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32320114

ABSTRACT

AIMS: This study evaluates the action of Weissella paramesenteroides WpK4 on amoebic colitis. METHODS AND RESULTS: Weissella paramesenteroides WpK4 was administered in Entamoeba dispar infected and noninfected mice and clinical parameters were evaluated. Following 7 days, the caeca were collected for histopathology, morphometry and immunohistochemical staining of MUC-2, CDC-47 and IgA. The treatment reduced diarrhoea and the presence of blood in the faeces and diminished the area of necrosis, also causing weight gain. Also, the addition of this bacterium enhanced the expression of the mucin (MUC-2). The reduction in necrosis and increased CDC-47 expression indicates significant epithelial regeneration. The negative correlation between CDC-47 and the necrosis area reveals that the bacterium favoured the recovery of the necrotic regions and the positive correlation found between the expression of MUC-2 and CDC-47 indicates that the epithelial regeneration also supports the synthesis of MUC-2. CONCLUSIONS: Weissella paramesenteroides WpK4 was able to increase the protection of the intestinal mucosa against experimental amoebic colitis through the increase of MUC-2 and epithelial regeneration. SIGNIFICANCE AND IMPACT OF THE STUDY: Weissella paramesenteroides WpK4 presents the potential to become a complementary tool in the treatment of amoebic colitis.


Subject(s)
Dysentery, Amebic/prevention & control , Intestinal Mucosa/physiology , Mucin-2/metabolism , Regeneration , Weissella/physiology , Animals , Disease Models, Animal , Dysentery, Amebic/pathology , Intestinal Mucosa/metabolism , Intestinal Mucosa/parasitology , Mice , Minichromosome Maintenance Complex Component 7/metabolism , Probiotics
3.
J Appl Microbiol ; 127(4): 1184-1191, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31155822

ABSTRACT

AIMS: The objective of this study was to assess the probiotic potential of genuine strains of Bifidobacterium longum 51A and Weissella paramesenteroides WpK4, in experimental giardiasis. METHODS AND RESULTS: The bacteria were administered orally to gerbils (Meriones unguiculatus) 10 days before oral infection with trophozoites of Giardia lamblia. After 7 days of infection, the animals were euthanized and portions of the duodenum were processed for histopathologic, histochemical and morphometric assessment. The height of the intestinal crypts and crypt/villi ratio were higher in infected groups (P < 0·05) than in noninfected groups. The area of mucus production was higher (P < 0·05) in infected animals pretreated with B. longum 51A than in other groups. The parasitic load of the animals that received both bacteria decreased significantly (P < 0·05) compared to the ones of the control group. CONCLUSIONS: Our results suggest a probiotic function of B. longum 51A and W. paramesenteroides WpK4 and may result in their use as a prophylactic and therapeutic alternative for promoting human and animal health. SIGNIFICANCE AND IMPACT OF THE STUDY: Bifidobacterium longum 51A and W. paramesenteroides WpK4 may constitute prophylactic alternatives, reversing the emergence of side effects and resistance observed in the conventional treatment of giardiasis.


Subject(s)
Bifidobacterium longum , Giardia lamblia/drug effects , Giardiasis , Probiotics/pharmacology , Weissella , Animals , Disease Models, Animal , Gerbillinae , Parasite Load
4.
Parasite Immunol ; 36(7): 303-12, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24749785

ABSTRACT

Schistosoma mansoni is a blood fluke parasite responsible for schistosomiasis. The best long-term strategy to control schistosomiasis is through immunization combined with drug treatment. In this study, we cloned, expressed and purified SmTSP-2 fused to the N- and C-terminal halves of Sm29 and tested these chimeras as vaccine candidates using an adjuvant approved to be used in humans. The results demonstrated that vaccination with SmTSP-2 fused to N- or C-terminus of Sm29-induced reduction in worm burden and liver pathology when compared to control animals. Additionally, we detected high levels of mouse-specific IgG, IgG1 and IgG2a against both chimeras and significant amounts of IFN-γ and TNF-α and no IL-4. Finally, studies with sera from patients resistant to infection and living in schistosomiasis endemic areas revealed high levels of specific IgG to both chimeras when compared to healthy individuals. In conclusion, SmTSP-2/Sm29 chimeras tested here induced partial protection against infection and might be a potential vaccine candidate.


Subject(s)
Antigens, Bacterial/immunology , Antigens, Helminth/immunology , Bacterial Proteins/immunology , Helminth Proteins/immunology , Membrane Glycoproteins/immunology , Schistosoma mansoni , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/prevention & control , Tetraspanins/immunology , Vaccines/immunology , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Helminth/blood , Antigens, Bacterial/administration & dosage , Antigens, Helminth/administration & dosage , Bacterial Proteins/administration & dosage , CpG Islands , Cytokines/blood , Female , Helminth Proteins/administration & dosage , Humans , Immunoglobulin G/blood , Liver/pathology , Membrane Glycoproteins/administration & dosage , Mice , Mice, Inbred C57BL , Oligodeoxyribonucleotides/administration & dosage , Recombinant Proteins/administration & dosage , Recombinant Proteins/immunology , Tetraspanins/administration & dosage , Vaccines/administration & dosage
5.
Oral Dis ; 19(5): 484-93, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23107153

ABSTRACT

OBJECTIVE: We evaluated the effects of sodium hyaluronate (HY) and carbon nanotubes functionalized with HY (HY-CNT) on bone repair in the tooth sockets of diabetic rats. MATERIALS AND METHODS: Diabetes was induced by streptozotocin (50 mg kg(-1) i.v.), and the sockets were divided into normal control, diabetic control, diabetic treated with HY (1%), and diabetic treated with HY-CNT (100 µg ml(-1)) groups. The sockets were analyzed according to the percentage of bone formation and the number of cell nuclei. RESULTS: The percentage of bone trabeculae was lower in diabetic control animals (11.16 ± 5.10% vs 41.92 ± 6.34% in normal animals) after 14 days. Treating diabetic animals with HY or HY-CNT significantly increased the percentage of neoformed trabeculae (HY: 29.43 ± 3.29%; HY-CNT: 36.90 ± 3.07%). Moreover, the sockets of diabetic animals had an increased number of cell nuclei and HY or HY-CNT reduced this parameter. CONCLUSION: Our results indicate that HY and HY-CNT restore bone repair in the tooth sockets of diabetic rats, suggesting that these biomaterials are potential adjuvant therapies for the management of diabetes.


Subject(s)
Bone Regeneration/drug effects , Diabetes Mellitus, Experimental , Hyaluronic Acid/pharmacology , Nanotubes, Carbon , Tooth Socket/drug effects , Animals , Male , Rats , Rats, Wistar
6.
Parasite Immunol ; 32(5): 345-53, 2010 May.
Article in English | MEDLINE | ID: mdl-20500663

ABSTRACT

Schistosomiasis is a parasitic disease with more than 200 million people infected worldwide. The formation of granulomas around eggs trapped in the liver is the main cause of disease morbidity. Therefore, the aim of this investigation was to characterize the immunopathological response induced by the recombinant (r) IPSE/alpha-1 egg protein in mice. Herein, we have shown that splenocytes from mice immunized with rIPSE/alpha-1 produced IFN-gamma, TNF-alpha, IL-4, IL-5 and IL-13 characterizing a mixed Th1/Th2 type of immune response. Pathological analysis of the liver revealed that there was no alteration in the number of eggs and granulomas; however, we observed an increase in granuloma area in immunized mice. Furthermore, eosinophil peroxidase assay showed that there was no alteration in the eosinophil infiltration in the liver; however, n-acetyl-beta-glucosaminidase measurement revealed an increase in macrophage activity. Despite the alteration in the profile of liver inflammatory cells in rIPSE immunized mice, the production of chemokines such as CCL2, CCL3, CCL5 and CCL11 was unaltered compared with the control group. In conclusion, IPSE/alpha-1 immunization induces a mixed Th1/Th2 type of immune response and enlargement of hepatic granuloma caused by an increased macrophage activity, but does not alter Th2 cytokines following infection.


Subject(s)
Egg Proteins/immunology , Helminth Proteins/immunology , Schistosoma mansoni/immunology , Schistosoma mansoni/pathogenicity , Schistosomiasis mansoni/pathology , Schistosomiasis mansoni/parasitology , Th2 Cells/immunology , Virulence Factors/immunology , Acetylglucosaminidase/metabolism , Animals , Cytokines/metabolism , Egg Proteins/genetics , Eosinophils/immunology , Female , Granuloma/immunology , Granuloma/parasitology , Granuloma/pathology , Helminth Proteins/genetics , Leukocytes, Mononuclear/immunology , Liver/parasitology , Liver/pathology , Macrophages/immunology , Mice , Mice, Inbred C57BL , Peroxidase/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Schistosomiasis mansoni/immunology , Spleen/immunology , Virulence Factors/genetics
7.
Parasite Immunol ; 32(11-12): 749-59, 2010.
Article in English | MEDLINE | ID: mdl-21039615

ABSTRACT

The surface of the schistosomula is an important target for host immune system attack because the tegument represents the interface between host and parasite and thus is a potential candidate for the development of new intervention strategies. In this study, we evaluated the ability of schistosomula tegument (Smteg) to induce protection in mice. Immunization of mice with Smteg together with Freund adjuvant induced a Th1 type of immune response associated with a significant reduction in worm burden (43-48%), eggs trapped in the liver (65%), eggs eliminated in the faeces (59-60%) and granuloma number (41%). Lastly, during an in vitro study, worms from mice immunized with Smteg showed damage in the adult worm tegument and impaired egg laying.


Subject(s)
Schistosoma mansoni/immunology , Schistosomiasis mansoni/prevention & control , Animals , Cytokines/biosynthesis , Disease Models, Animal , Feces/parasitology , Female , Freund's Adjuvant/administration & dosage , Liver/parasitology , Mice , Mice, Inbred C57BL , Parasite Egg Count , Schistosoma mansoni/ultrastructure , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/parasitology , Schistosomiasis mansoni/pathology , Th1 Cells/immunology , Vaccines, Subunit/administration & dosage , Vaccines, Subunit/immunology
8.
Parasitology ; 137(7): 1079-88, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19835649

ABSTRACT

Proteins associated with the schistosome tegument are of great importance for the development of new intervention strategies since they may be exposed on the surface of the parasite. Herein, we have isolated a cDNA clone encoding for the Schistosoma mansoni SmIg and its recombinant protein was tested as a potential vaccine candidate. Initially, its amino acid sequence was analysed by bioinformatics and shown to possess an N-terminal signal peptide, a C-terminal transmembrane helix, 4 glycosylation sites, an immunoglobulin conserved domain and 73% similarity with a hypothetical S. japonicum protein of unknown function. SmIg was produced by E. coli as a recombinant protein (rSmIg) and its protective effectiveness was evaluated against S. mansoni infection with 100 cercariae in a murine model. Mice immunized with rSmIg induced an immune response characterized by dominant IgG1 isotype and significant levels of IFN-gamma, TNF-alpha, IL-10 and IL-4. Although immunogenic, the recombinant vaccine failed to induce worm burden reduction when compared to the infected control group. However, rSmIg-immunized mice had significant reductions of liver granuloma volume and fibrosis content by 31.8% and 49%, respectively. In conclusion, SmIg is a new tegument protein from S. mansoni that plays an important role in reducing pathology induced by parasite infection.


Subject(s)
Antigens, Helminth/administration & dosage , Helminth Proteins/administration & dosage , Liver/immunology , Liver/pathology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/prevention & control , Vaccines, DNA/administration & dosage , Amino Acid Sequence , Animals , Antibodies, Helminth/blood , Antigens, Helminth/genetics , Antigens, Helminth/immunology , Female , Helminth Proteins/chemistry , Helminth Proteins/genetics , Helminth Proteins/immunology , Immunization , Immunoglobulin G/blood , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Schistosomiasis mansoni/immunology , Vaccines, DNA/genetics , Vaccines, DNA/immunology
9.
J Periodontal Res ; 44(2): 153-60, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19210344

ABSTRACT

BACKGROUND AND OBJECTIVE: Periodontal disease is an inflammatory condition of tooth-supporting tissues. Arachidonic acid metabolites have been implicated in development of periodontal disease, especially those derived from the cyclo-oxygenase (COX) pathway. This study investigated the role of inhibitors of cyclo-oxygenases (COX-1 and COX-2) in a model of periodontal disease in rats. MATERIAL AND METHODS: A ligature was placed around the molar of rats. Losses of fiber attachment and of alveolar bone were measured morphometrically in histologically prepared sections. Infiltration of cells into gingival tissue surrounding the ligated tooth was also determined. RESULTS: Systemic and local administration of non-selective and selective COX-2 inhibitors, preventively, resulted in significant reduction of the losses of fiber attachment and alveolar bone, as well as decreased leukocyte numbers in gingival tissue. Preventive selective inhibition of COX-1 was as effective as COX-2 inhibition in reducing local fiber attachment loss and cell migration, but did not prevent alveolar bone loss. CONCLUSION: Our results provide evidence for participation of COX-1 and COX-2 in early stages of periodontal disease in rats. Furthermore, local administration of COX inhibitors reduced the signs of periodontal disease to the same extent as systemic treatment. Therapeutic approaches incorporating locally delivered anti-inflammatory drugs could be of benefit for patients suffering from periodontal disease.


Subject(s)
Alveolar Bone Loss/enzymology , Cyclooxygenase Inhibitors/pharmacology , Periodontal Attachment Loss/enzymology , Periodontitis/enzymology , Prostaglandin-Endoperoxide Synthases/metabolism , Alveolar Bone Loss/drug therapy , Animals , Arachidonic Acid/metabolism , Celecoxib , Cyclooxygenase Inhibitors/therapeutic use , Disease Models, Animal , Indomethacin/pharmacology , Male , Periodontal Attachment Loss/drug therapy , Periodontal Ligament/drug effects , Periodontitis/drug therapy , Pyrazoles/pharmacology , Rats , Rats, Sprague-Dawley , Sulfonamides/pharmacology
10.
Int Endod J ; 42(10): 922-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19751291

ABSTRACT

AIM: To design and validate a rat molar model of furcal perforation to allow investigation of the biological phenomena that follow and to explore its potential for evaluating repair materials under standardized conditions. METHODOLOGY: Eighteen male Wistar rats were used. Surgical aseptic procedures were carried out in order to open the pulp chamber of a first molar tooth. A cavity was prepared on the floor of the pulp chamber using a (1/4) round bur that created a communication between the furcation and the periodontal tissues. Six animals for each time point were sacrificed on days 14, 21 and 28 to assay morphological changes at the furcation region of molars. Maxillary bone was processed, removed and sectioned. Cellular infiltration, collagen deposition and bone resorption were assessed by histological analysis. Cellularity in the lesion area was determined by morphometric analysis. Data were analysed using parametric Student's t-test. RESULTS: A furcal perforation model was standardized in which both radiological outcome and periodontal tissue reactions could be assessed through evaluation of cellularity, osteoclast activity and collagen deposition. The morphometric analysis revealed a greater number of cells 21 day post-surgery when compared with 14 days. CONCLUSION: This animal model was suitable for radiological and histological evaluation of the processes that accompany surgical furcal perforation.


Subject(s)
Dental Pulp Cavity/injuries , Root Canal Preparation/adverse effects , Aluminum Compounds/therapeutic use , Alveolar Process/injuries , Alveolar Process/pathology , Animals , Bone Resorption/etiology , Bone Resorption/pathology , Calcium Compounds/therapeutic use , Collagen , Dental Pulp/pathology , Dental Pulp Cavity/pathology , Dentin/pathology , Disease Models, Animal , Drug Combinations , Granulation Tissue/pathology , Gutta-Percha/therapeutic use , Male , Maxilla/injuries , Maxilla/pathology , Molar/injuries , Molar/pathology , Neovascularization, Physiologic/physiology , Neutrophils/pathology , Osteoclasts/pathology , Oxides/therapeutic use , Periodontium/injuries , Periodontium/pathology , Pulpectomy , Rats , Rats, Wistar , Root Canal Filling Materials/therapeutic use , Root Canal Preparation/instrumentation , Silicates/therapeutic use , Wound Healing/physiology
11.
J Periodontal Res ; 43(6): 730-6, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18705652

ABSTRACT

BACKGROUND AND OBJECTIVE: Periodontal disease is a chronic inflammatory condition of the tooth supporting tissues, the periodontium. Opioids have been shown to account for the relief of various chronic and acute inflammatory conditions. The aim of the present study was to investigate the participation of peripheral opioid receptors in development of periodontal disease. MATERIAL AND METHODS: Morphine and selective agonists and antagonists of opioid receptors were used in an experimental model of ligature-induced periodontal disease in rats. To evaluate the development of disease, the loss of fiber attachment, alveolar bone and number of cells in periodontal tissues were assessed. Measurements of these indicators were obtained by morphometric analysis of histological sections of periodontal-diseased tissues stained with hematoxylin and eosin. RESULTS: Local administration of either morphine or a selective kappa-opioid agonist for three consecutive days from the onset of periodontal disease reduced the loss of periodontal tissues, without changing the number of leukocytes in inflamed periodontium. Nor-binaltorphimine, a selective kappa-antagonist, reversed the beneficial effects of both morphine and the compound U-50,488 in this model. The use of either an agonist or an antagonist of delta-opioid receptors, however, did not affect disease progression. CONCLUSION: Our results showed that the beneficial effect of opioids in periodontal disease depended mainly on the activation of specific kappa-opioid receptors located in the periphery. Activation of such receptors could be considered in the management of periodontal disease, since it would not present the classical central side-effects associated with opioid use.


Subject(s)
Chronic Periodontitis/drug therapy , Chronic Periodontitis/physiopathology , Receptors, Opioid, kappa/physiology , 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/pharmacology , Analgesics, Opioid/pharmacology , Analgesics, Opioid/therapeutic use , Animals , Disease Models, Animal , Male , Morphine/pharmacology , Morphine/therapeutic use , Naltrexone/analogs & derivatives , Naltrexone/pharmacology , Narcotic Antagonists/pharmacology , Peripheral Nervous System/physiology , Rats , Rats, Sprague-Dawley , Receptors, Opioid, delta/physiology , Receptors, Opioid, kappa/agonists , Receptors, Opioid, kappa/antagonists & inhibitors
12.
Benef Microbes ; 9(5): 789-797, 2018 Sep 18.
Article in English | MEDLINE | ID: mdl-30165752

ABSTRACT

The aim of the study was to assess the efficacy of Saccharomyces boulardii in experimental treatment of giardiasis and its impact on intestinal integrity and some functions of gerbils infected with Giardia lamblia. 28 gerbils (Meriones unguiculatus), aged 4-6 weeks, were divided into four groups: untreated and uninfected control (CT); infected with G. lamblia (IGL); treated with S. boulardii (SB); and infected with G. lamblia and treated with S. boulardii (ITSB). The SB and ITSB groups received S. boulardii 15 days prior to being infected with G. lamblia. The treatment continued until completion of the experiment (22nd day). The IGL and ITSB groups were gavage-inoculated with G. lamblia ensuring one-week infection. 4 h before euthanasia, all animals were gavaged with a solution containing diethylenetriamine-pentaacetic acid (DTPA) marked with technetium-99mTc DTPA to determine intestinal permeability. The small intestine was removed for histopathological, morphometric analysis and count of trophozoites adhered to the mucosa. The selected probiotic caused an approximate reduction of 70% of parasite load, which was determined by attached trophozoites (P<0.01) and immune-marked trophozoites (P<0.05). Treatment with S. boulardii (SB and ITSB groups) also increased the height of the intestinal villi and crypt depth compared to the CT and IGL groups (P<0.05). The area of mucus production and the number of goblet cells of the SB and ITSB groups were higher compared to the CT and IGL groups (P<0.01). The animals treated with S. boulardii also exhibited a significant increase of intraepithelial lymphocytes counts (P<0.01). There was no difference in the intestinal permeability between the groups studied. The efficacy of S. boulardii in reducing damages caused by Giardia was demonstrated, with an approximate reduction of 70% of the parasite load, suggesting its use as a coadjuvant in giardiasis treatment.


Subject(s)
Giardia lamblia/physiology , Giardiasis/drug therapy , Probiotics/administration & dosage , Saccharomyces boulardii/physiology , Animals , Disease Models, Animal , Gerbillinae , Giardia lamblia/drug effects , Giardia lamblia/growth & development , Giardiasis/parasitology , Humans , Intestine, Small/parasitology , Intestine, Small/pathology , Male
13.
Vet Immunol Immunopathol ; 117(1-2): 129-36, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17383741

ABSTRACT

Leishmania promastigotes interact with macrophages through the association of multiple membrane surface receptors. Macrophage complement receptor CR3 (CD11b/CD18 or Mac-1) has been implicated in the interaction of both human and murine macrophages with serum-opsonized promastigotes. The aim of this study was to determine CR3 expression in the livers and spleens of dogs naturally infected with Leishmania (Leishmania) chagasi. CR3 expression in liver was higher in asymptomatic than in symptomatic animals. Moreover, the hepatic parasitism load determined by immunocytochemical analysis was lower in parallel with higher numbers of granulomas. In contrast, in spleens, CR3 expression was higher in symptomatic animals than in asymptomatic ones. However, the tissue parasite load was greater in spleens of symptomatic dogs. There was a strict correlation between the parasite load and cellular CR3 expression in the spleens of dogs naturally infected with L. chagasi. CR3 macrophage integrins could be essential receptors for Leishmania survival. Considering that the symptomatic animals showed higher parasite loads and higher CD11b/CD18 expression in their spleens, we can conclude that these splenic cells (monocyte-macrophages) might serve to perpetuate intracellular infection.


Subject(s)
Dog Diseases/parasitology , Leishmania infantum/immunology , Leishmaniasis, Visceral/veterinary , Liver Diseases, Parasitic/veterinary , Macrophage-1 Antigen/immunology , Splenic Diseases/veterinary , Animals , CD11b Antigen/immunology , CD18 Antigens/immunology , Dog Diseases/immunology , Dogs , Immunohistochemistry/veterinary , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/parasitology , Liver Diseases, Parasitic/immunology , Liver Diseases, Parasitic/parasitology , Splenic Diseases/immunology , Splenic Diseases/parasitology
14.
Parasite ; 14(4): 329-34, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18225422

ABSTRACT

Evolution of experimental hepatic lesions produced in hamsters with Entamoeba histolytica and E. dispar was evaluated quantitatively and qualitatively through morphometry and immunohistochemistry. Animals infected with E. dispar developed hepatic lesions quantitatively and qualitatively similar to those produced by E. histolytica on the first three days of infection. On the 6th and 8th days of infection, E. histolytica produced larger tissue damage than E. dispar. A gradual decrease was observed in the number of trophozoites along the infection. A negative correlation was observed between the reduced number of trophozoites and the larger area of necrosis in both groups, confirming the importance of trophozoites killed in the lesion genesis. Regarding the genetic similarity between E. histolytica and E. dispar, comparison strategy between lesions produced by these species may culminate in identifying virulence factors of E. histolytica.


Subject(s)
Cricetinae/parasitology , Entamoeba histolytica/pathogenicity , Entamoeba/pathogenicity , Liver/pathology , Liver/parasitology , Animals , Immunohistochemistry/veterinary , Virulence
15.
Biomed Pharmacother ; 96: 269-278, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28988012

ABSTRACT

The proteolytic enzymes from Vasconcellea cundinamarcensis have demonstrated efficacy to accelerate healing of skin lesions. We report here the efficacy of the proteolytic fraction - P1G10 during repair of excisional wounds in rodent model and analyze possible mediators involved. Using 0.05% P1G10 we observed on day 3rd increased wound contraction accompanied by an increase in activated neutrophils and VEGF relative to the control. On day 7th neutrophils returned to normal levels, and at 0.01% P1G10, an increase in NAG activity used to monitor monocyte/macrophage, was observed. On the other hand, on day 7th, we observed a decrease in TGF-ß at 0.05% P1G10, accompanied by an increased transformation of the latent TGF-ß to its active form. Also, on day 7th a reduction in MMP-9 activity and the number of apoptotic cells was observed along with an increase in fibroblast levels. Morphometrically, it appears that treatment with P1G10 accelerates the decline of initial inflammatory phase and reduces some unwanted effects likely caused by remaining TGF-ß or MMPs, thus enhancing the quality of scar. Overall, these data suggest that the active proteolytic fraction P1G10 enhances the efficacy of repair in excisional cutaneous wounds.


Subject(s)
Carica , Latex/pharmacology , Plant Extracts/pharmacology , Proteolysis , Skin/drug effects , Wound Healing/drug effects , Animals , Latex/isolation & purification , Male , Mice , Mice, Inbred C57BL , Peptide Hydrolases/isolation & purification , Peptide Hydrolases/pharmacology , Plant Extracts/isolation & purification , Proteolysis/drug effects , Skin/pathology , Wound Healing/physiology
16.
Eur J Histochem ; 59(4): 2546, 2015 Oct 26.
Article in English | MEDLINE | ID: mdl-26708180

ABSTRACT

In canine visceral leishmaniasis a diffuse chronic inflammatory exudate and an intense parasite load throughout the gastrointestinal tract has been previously reported. However, these studies did not allow a properly description of canine cellular morphology details. The aim of our study was to better characterize these cells in carrying out a qualitative and quantitative histological study in the gastrointestinal tract of dogs naturally infected with Leishmania infantum by examining gut tissues embedded in glycol methacrylate. Twelve infected adult dogs were classified in asymptomatic and symptomatic. Five uninfected dogs were used as controls. After necropsy, three samples of each gut segment, including esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, and rectum were collected and fixed in Carnoy's solution for glycol methacrylate protocols. Sections were stained with hematoxylin-eosin, toluidine blue borate, and periodic acid-Schiff stain. Leishmania amastigotes were detected by immunohistochemistry employed in both glycol methacrylate and paraffin embedded tissues. The quantitative histological analysis showed higher numbers of plasma cells, lymphocytes and macrophages in lamina propria of all segments of GIT of infected dogs than controls. The parasite load was more intense and cecum and colon, independently of the clinical status of these dogs. Importantly, glycol methacrylate embedded tissue stained with toluidine blue borate clearly revealed mast cell morphology, even after mast cell degranulation. Infected dogs showed lower numbers of mast cells in all gut segments than did controls. Despite the glycol methacrylate (GMA) protocol requires more attention and care than the conventional paraffin processing, this embedding procedure proved to be especially suitable for the present histological study, where it allowed to preserve and observe cell morphology in fine detail.


Subject(s)
Dog Diseases , Gastrointestinal Tract , Leishmania infantum/metabolism , Leishmaniasis, Visceral , Methacrylates/chemistry , Plastic Embedding/methods , Animals , Dog Diseases/metabolism , Dog Diseases/pathology , Dogs , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/parasitology , Immunohistochemistry/methods , Leishmaniasis, Visceral/metabolism , Leishmaniasis, Visceral/pathology
17.
Br J Pharmacol ; 172(9): 2330-42, 2015 May.
Article in English | MEDLINE | ID: mdl-25559763

ABSTRACT

BACKGROUND AND PURPOSE: A long-term imbalance between pro- and anti-inflammatory mediators leads to airway remodelling, which is strongly correlated to most of the symptoms, severity and progression of chronic lung inflammation. The Angiotensin-(1-7) [Ang-(1-7)]/Mas receptor axis of the renin-angiotensin system is associated with attenuation of acute and chronic inflammatory processes. In this study, we investigated the effects of Ang-(1-7) treatment in a model of chronic allergic lung inflammation. EXPERIMENTAL APPROACH: Mice were sensitized to ovalbumin (OVA; 4 injections over 42 days, 14 days apart) and were challenged three times per week (days 21-46). These mice received Ang-(1-7) (1 µg·h(-1) , s.c.) by osmotic mini-pumps, for the last 28 days. Histology and morphometric analysis were performed in left lung and right ventricle. Airway responsiveness to methacholine, analysis of Ang-(1-7) levels (RIA), collagen I and III (qRT-PCR), ERK1/2 and JNK (Western blotting), IgE (elisa), cytokines and chemokines (elisa multiplex), and immunohistochemistry for Mas receptors were performed. KEY RESULTS: Infusion of Ang-(1-7) in OVA-sensitized and challenged mice decreased inflammatory cell infiltration and collagen deposition in the airways and lung parenchyma, and prevented bronchial hyperresponsiveness. These effects were accompanied by decreased IgE and ERK1/2 phosphorylation, and decreased pro-inflammatory cytokines. Mas receptors were detected in the epithelium and bronchial smooth muscle, suggesting a site in the lung for the beneficial actions of Ang-(1-7). CONCLUSIONS AND IMPLICATIONS: Ang-(1-7) exerted beneficial attenuation of three major features of chronic asthma: lung inflammation, airway remodelling and hyperresponsiveness. Our results support an important protective role of Ang-(1-7) in lung inflammation.


Subject(s)
Airway Remodeling/drug effects , Angiotensin I/pharmacology , Anti-Inflammatory Agents/pharmacology , Bronchial Hyperreactivity/prevention & control , Bronchoconstriction/drug effects , Lung/drug effects , Peptide Fragments/pharmacology , Pneumonia/prevention & control , Respiratory Hypersensitivity/prevention & control , Animals , Bronchial Hyperreactivity/chemically induced , Bronchial Hyperreactivity/metabolism , Bronchial Hyperreactivity/physiopathology , Collagen/metabolism , Cytokines/metabolism , Disease Models, Animal , Hypertrophy, Right Ventricular/chemically induced , Hypertrophy, Right Ventricular/physiopathology , Hypertrophy, Right Ventricular/prevention & control , Immunoglobulin E/blood , Inflammation Mediators/metabolism , Lung/metabolism , Lung/physiopathology , Male , Mice, Inbred BALB C , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Ovalbumin , Phosphorylation , Pneumonia/chemically induced , Pneumonia/metabolism , Pneumonia/physiopathology , Proto-Oncogene Mas , Proto-Oncogene Proteins/agonists , Proto-Oncogene Proteins/metabolism , Receptors, G-Protein-Coupled/agonists , Receptors, G-Protein-Coupled/metabolism , Respiratory Hypersensitivity/chemically induced , Respiratory Hypersensitivity/metabolism , Respiratory Hypersensitivity/physiopathology , Signal Transduction/drug effects
18.
Eur J Histochem ; 59(2): 2489, 2015 Apr 27.
Article in English | MEDLINE | ID: mdl-26150158

ABSTRACT

Infection with Helicobacter pylori strains containing high number of EPIYA-C phosphorylation sites in the CagA is associated with significant gastritis and increased risk of developing pre-malignant gastric lesions and gastric carcinoma. However, these findings have not been reproduced in animal models yet. Therefore, we investigated the effect on the gastric mucosa of Mongolian gerbil (Meriones unguiculatus) infected with CagA-positive H. pylori strains exhibiting one or three EPIYA-C phosphorilation sites. Mongolian gerbils were inoculated with H. pylori clonal isolates containing one or three EPIYA-C phosphorylation sites. Control group was composed by uninfected animals challenged with Brucella broth alone. Gastric fragments were evaluated by the modified Sydney System and digital morphometry. Clonal relatedness between the isolates was considered by the identical RAPD-PCR profiles and sequencing of five housekeeping genes, vacA i/d region and of oipA. The other virulence markers were present in both isolates (vacA s1i1d1m1, iceA2, and intact dupA). CagA of both isolates was translocated and phosphorylated in AGS cells. After 45 days of infection, there was a significant increase in the number of inflammatory cells and in the area of the lamina propria in the infected animals, notably in those infected by the CagA-positive strain with three EPIYA-C phosphorylation sites. After six months of infection, a high number of EPIYA-C phosphorylation sites was associated with progressive increase in the intensity of gastritis and in the area of the lamina propria. Atrophy, intestinal metaplasia, and dysplasia were also observed more frequently in animals infected with the CagA-positive isolate with three EPIYA-C sites.  We conclude that infection with H. pylori strain carrying a high number of CagA EPIYA-C phosphorylation sites is associated with more severe gastric lesions in an animal model of H. pylori infection.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , Helicobacter Infections/pathology , Stomach/pathology , Aged , Amino Acid Sequence , Animals , Base Sequence , DNA, Bacterial/genetics , Disease Progression , Female , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gerbillinae , Helicobacter Infections/microbiology , Humans , Molecular Sequence Data , Phosphorylation , Protein Transport , Stomach Neoplasms/pathology , Urease/analysis , Urease/metabolism
19.
Am J Trop Med Hyg ; 59(3): 492-6, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9749650

ABSTRACT

Heart autonomic innervation was studied in dogs during the acute phase of the experimental infection with the Berenice-78 strain of Trypanosoma cruzi. A glyoxylic acid-induced fluorescence method for catecholamines and a thiocholine method for demonstrating acetylcholinesterase activity showed the sympathetic and the parasympathetic nerve fibers, respectively. At day 34 of infection, moderate-to-intense rarefaction of both cholinergic and noradrenergic nerve fibers occurred in the atria of all animals coincident with moderate to intense myocarditis. In the ventricles, sympathetic denervation was clearly present only when the inflammatory processes were moderate to intense. Preliminary results on the chronic phase indicate that normal autonomic innervation coexists with an incipient chronic fibrosing myocarditis.


Subject(s)
Autonomic Nervous System/pathology , Chagas Disease/pathology , Heart/innervation , Acetylcholinesterase/analysis , Acute Disease , Animals , Autonomic Nervous System/chemistry , Autonomic Nervous System/enzymology , Catecholamines/analysis , Disease Models, Animal , Dogs , Heart Atria/innervation , Heart Ventricles/innervation , Histocytochemistry
20.
Inflammation ; 23(6): 569-81, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10565570

ABSTRACT

The diabetic organism is unable to produce normal amount of granulation tissue which results in delayed wound healing, a significant clinical problem. In the present study, the effect of oral administration of aminoguanidine (AG), in the diabetes-induced inhibition of angiogenesis and granulation tissue formation was tested. Subcutaneous implantation of sponge discs in nondiabetic rats induced a wound repair response as determined by the amount of hemoglobin (vascular index) and granulation tissue formation (morphometric analysis) of the implants. In the streptozotocin-induced diabetic rats the predominant response indicative of healing was inhibitory. Aminoguanidine was effective in preventing in 50% the diabetes-induced inhibition of fibrovascular tissue growth in the implants, as indicated by the values of hemoglobin content and vascular growth areas of the implants. These results indicate that AG holds potential therapeutic value in the management of healing impairment of the diabetic condition.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Enzyme Inhibitors/administration & dosage , Guanidines/administration & dosage , Neovascularization, Pathologic/drug therapy , Wound Healing/drug effects , Administration, Oral , Animals , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/physiopathology , Male , Rats , Rats, Wistar , Streptozocin
SELECTION OF CITATIONS
SEARCH DETAIL